Deferoxamine injection does not affect bleomycin-induced lung fibrosis in rats

Carroll E Cross, Darren Warren, Joan E. Gerriets, Dennis W Wilson, Barry Halliwell, Jerold A Last

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Bleomycin is an antineoplastic agent that causes a dose-related lung fibrosis that limits its therapeutic effectiveness. It has been proposed that the cellula toxicity and antitumor effects of bleomycin occur by formation of O2-Fe(II)-bleomycin complexes that degrade DNA and release O2 - and OH radicals that attack other cellular components. Twice daily injections of the iron chelator deferoxamine were utilized in an attempt to amellorate bleomycin-induced lung fibrosis. They failed to diminish bleomycin-induced lung inflammation and fibrosis in rats.

Original languageEnglish (US)
Pages (from-to)428-432
Number of pages5
JournalThe Journal of Laboratory and Clinical Medicine
Volume106
Issue number4
StatePublished - 1985

Fingerprint

Deferoxamine
Bleomycin
Rats
Fibrosis
Lung
Injections
Chelating Agents
Antineoplastic Agents
Toxicity
Pneumonia
Iron
DNA
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

Deferoxamine injection does not affect bleomycin-induced lung fibrosis in rats. / Cross, Carroll E; Warren, Darren; Gerriets, Joan E.; Wilson, Dennis W; Halliwell, Barry; Last, Jerold A.

In: The Journal of Laboratory and Clinical Medicine, Vol. 106, No. 4, 1985, p. 428-432.

Research output: Contribution to journalArticle

@article{345d390851e0488484fa13576ea926e3,
title = "Deferoxamine injection does not affect bleomycin-induced lung fibrosis in rats",
abstract = "Bleomycin is an antineoplastic agent that causes a dose-related lung fibrosis that limits its therapeutic effectiveness. It has been proposed that the cellula toxicity and antitumor effects of bleomycin occur by formation of O2-Fe(II)-bleomycin complexes that degrade DNA and release O2 - and OH radicals that attack other cellular components. Twice daily injections of the iron chelator deferoxamine were utilized in an attempt to amellorate bleomycin-induced lung fibrosis. They failed to diminish bleomycin-induced lung inflammation and fibrosis in rats.",
author = "Cross, {Carroll E} and Darren Warren and Gerriets, {Joan E.} and Wilson, {Dennis W} and Barry Halliwell and Last, {Jerold A}",
year = "1985",
language = "English (US)",
volume = "106",
pages = "428--432",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Deferoxamine injection does not affect bleomycin-induced lung fibrosis in rats

AU - Cross, Carroll E

AU - Warren, Darren

AU - Gerriets, Joan E.

AU - Wilson, Dennis W

AU - Halliwell, Barry

AU - Last, Jerold A

PY - 1985

Y1 - 1985

N2 - Bleomycin is an antineoplastic agent that causes a dose-related lung fibrosis that limits its therapeutic effectiveness. It has been proposed that the cellula toxicity and antitumor effects of bleomycin occur by formation of O2-Fe(II)-bleomycin complexes that degrade DNA and release O2 - and OH radicals that attack other cellular components. Twice daily injections of the iron chelator deferoxamine were utilized in an attempt to amellorate bleomycin-induced lung fibrosis. They failed to diminish bleomycin-induced lung inflammation and fibrosis in rats.

AB - Bleomycin is an antineoplastic agent that causes a dose-related lung fibrosis that limits its therapeutic effectiveness. It has been proposed that the cellula toxicity and antitumor effects of bleomycin occur by formation of O2-Fe(II)-bleomycin complexes that degrade DNA and release O2 - and OH radicals that attack other cellular components. Twice daily injections of the iron chelator deferoxamine were utilized in an attempt to amellorate bleomycin-induced lung fibrosis. They failed to diminish bleomycin-induced lung inflammation and fibrosis in rats.

UR - http://www.scopus.com/inward/record.url?scp=46549094624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46549094624&partnerID=8YFLogxK

M3 - Article

C2 - 2413151

AN - SCOPUS:46549094624

VL - 106

SP - 428

EP - 432

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 4

ER -